Dyne Therapeutics
(NASDAQ:DYN)
$28.66
0.16[0.56%]
Last update: 2:48PM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$56.00
Lowest Price Target1
$22.00
Consensus Price Target1
$37.38

Dyne Therapeutics Stock (NASDAQ:DYN), Analyst Ratings, Price Targets, Predictions

Dyne Therapeutics Inc has a consensus price target of $37.38, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Chardan Capital, and Guggenheim on March 26, 2024, March 8, 2024, and March 7, 2024. With an average price target of $38.33 between Oppenheimer, Chardan Capital, and Guggenheim, there's an implied 34.50% upside for Dyne Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Jan
1
Feb
1
Mar
7
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Chardan Capital
Guggenheim
HC Wainwright & Co.
Stifel

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Dyne Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/26/2024DYNBuy Now
Dyne Therapeutics
$28.5064.91%Oppenheimer
Francois Brisebois
$47 → $47ReiteratesOutperform → OutperformGet Alert
03/08/2024DYNBuy Now
Dyne Therapeutics
$28.508.77%Chardan Capital
Keay Nakae
$20 → $31MaintainsBuyGet Alert
03/07/2024DYNBuy Now
Dyne Therapeutics
$28.5029.82%Guggenheim
Debjit Chattopadhyay
$33 → $37MaintainsBuyGet Alert
03/06/2024DYNBuy Now
Dyne Therapeutics
$28.5026.32%HC Wainwright & Co.
Andrew Fein
→ $36ReiteratesBuy → BuyGet Alert
03/06/2024DYNBuy Now
Dyne Therapeutics
$28.5043.86%Stifel
Paul Matteis
$35 → $41MaintainsBuyGet Alert
03/06/2024DYNBuy Now
Dyne Therapeutics
$28.501.75%Piper Sandler
Edward Tenthoff
$27 → $29MaintainsOverweightGet Alert
03/05/2024DYNBuy Now
Dyne Therapeutics
$28.5064.91%Oppenheimer
Francois Brisebois
$44 → $47ReiteratesOutperform → OutperformGet Alert
02/20/2024DYNBuy Now
Dyne Therapeutics
$28.5026.32%HC Wainwright & Co.
Andrew Fein
→ $36Initiates → BuyGet Alert
01/04/2024DYNBuy Now
Dyne Therapeutics
$28.5096.49%Raymond James
Steven Seedhouse
$27 → $56MaintainsStrong BuyGet Alert
08/09/2023DYNBuy Now
Dyne Therapeutics
$28.50-22.81%JP Morgan
Tessa Romero
$20 → $22MaintainsOverweightGet Alert
08/04/2023DYNBuy Now
Dyne Therapeutics
$28.50-29.82%Chardan Capital
Keay Nakae
→ $20ReiteratesBuy → BuyGet Alert
03/03/2023DYNBuy Now
Dyne Therapeutics
$28.50-29.82%Chardan Capital
Keay Nakae
$17 → $20MaintainsBuyGet Alert
02/27/2023DYNBuy Now
Dyne Therapeutics
$28.50-5.26%Raymond James
Steven Seedhouse
$16 → $27UpgradeOutperform → Strong BuyGet Alert
02/15/2023DYNBuy Now
Dyne Therapeutics
$28.5019.3%Oppenheimer
Francois Brisebois
→ $34Initiates → OutperformGet Alert
01/26/2023DYNBuy Now
Dyne Therapeutics
$28.5015.79%Guggenheim
Debjit Chattopadhyay
→ $33Initiates → BuyGet Alert
11/29/2022DYNBuy Now
Dyne Therapeutics
$28.50-36.84%JP Morgan
Tessa Romero
$24 → $18MaintainsOverweightGet Alert
11/04/2022DYNBuy Now
Dyne Therapeutics
$28.50-43.86%Raymond James
Steven Seedhouse
$15 → $16MaintainsOutperformGet Alert
07/20/2022DYNBuy Now
Dyne Therapeutics
$28.50-40.35%Chardan Capital
Keay Nakae
→ $17Initiates → BuyGet Alert
07/12/2022DYNBuy Now
Dyne Therapeutics
$28.50-47.37%Raymond James
Steven Seedhouse
→ $15Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Dyne Therapeutics (DYN)?

A

The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by Oppenheimer on March 26, 2024. The analyst firm set a price target for $47.00 expecting DYN to rise to within 12 months (a possible 63.99% upside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Dyne Therapeutics (DYN)?

A

The latest analyst rating for Dyne Therapeutics (NASDAQ: DYN) was provided by Oppenheimer, and Dyne Therapeutics reiterated their outperform rating.

Q

When was the last upgrade for Dyne Therapeutics (DYN)?

A

The last upgrade for Dyne Therapeutics Inc happened on February 27, 2023 when Raymond James raised their price target to $27. Raymond James previously had an outperform for Dyne Therapeutics Inc.

Q

When was the last downgrade for Dyne Therapeutics (DYN)?

A

There is no last downgrade for Dyne Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Dyne Therapeutics (DYN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dyne Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dyne Therapeutics was filed on March 26, 2024 so you should expect the next rating to be made available sometime around March 26, 2025.

Q

Is the Analyst Rating Dyne Therapeutics (DYN) correct?

A

While ratings are subjective and will change, the latest Dyne Therapeutics (DYN) rating was a reiterated with a price target of $47.00 to $47.00. The current price Dyne Therapeutics (DYN) is trading at is $28.66, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch